{35 (lamotrigine 25 MG Oral Tablet [Subvenite]) } Pack [Subvenite Blue (for Patients Taking Valproate)]

RxCUI
2003799
RxNorm name
{35 (lamotrigine 25 MG Oral Tablet [Subvenite]) } Pack [Subvenite Blue (for Patients Taking Valproate)]
Display name
{35 (lamotrigine 25 MG Oral Tablet [Subvenite]) } Pack [Subvenite Blue (for Patients Taking Valproate)]
Full name
{35 (lamotrigine 25 MG Oral Tablet [Subvenite]) } Pack [Subvenite Blue (for Patients Taking Valproate)]
Term type
BPCK
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SUBVENITELAMOTRIGINEOWP Pharmaceuticals, Inc.7ad18b68-ba16-4810-9c3e-27fa970454e82026-03-27Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2003799

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
7ad18b68-ba16-4810-9c3e-27fa970454e8{35 (lamotrigine 25 MG Oral Tablet [Subvenite]) } Pack [Subvenite Blue (for Patients Taking Valproate)]BPCK15These highlights do not include all the information needed to use SUBVENITE safely and effectively. See full prescribing information for SUBVENITE. SUBVENITE (lamotrigine) tablets, for oral use Initial U.S. Approval: 199420260327
7ad18b68-ba16-4810-9c3e-27fa970454e8Subvenite Starter Kit Blue 25 MG 35 CountPSN15These highlights do not include all the information needed to use SUBVENITE safely and effectively. See full prescribing information for SUBVENITE. SUBVENITE (lamotrigine) tablets, for oral use Initial U.S. Approval: 199420260327
7ad18b68-ba16-4810-9c3e-27fa970454e8Subvenite Blue Kit (for Patients Taking Valproate)SY15These highlights do not include all the information needed to use SUBVENITE safely and effectively. See full prescribing information for SUBVENITE. SUBVENITE (lamotrigine) tablets, for oral use Initial U.S. Approval: 199420260327